Article
Nucleotide Prodrugs for HCV Therapy
23 Aug 2011
Abstract excerpt
HCV infection is a significant worldwide health problem and is a major cause of hepatocellular carcinoma. The current standard of care, interferon and ribavirin, is only effective against a proportion of the patient population infected with HCV. To address the shortcomings of existing therapy, the development of direct acting antiviral agents is under investigation. The HCV RNA dependent RNA polymerase is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
